الولايات المتحدة · منصات وبيانات · MarketBeat

Mirum Pharmaceuticals (NASDAQ:MIRM) Stock Price Expected to Rise, Citigroup Analyst Says

نشره MarketBeat · الولايات المتحدة منذ 27 د

Image from MarketBeat Media, LLC. · MarketBeat

ملخص مفصل

Citigroup increased their price objective on Mirum Pharmaceuticals from $184.00 to $194.00 and gave the stock a "buy" rating in a research note on Wednesday.

اقرأ المقال كاملًا على MarketBeat سجّل الدخول للحفظ

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (www.marketbeat.com)

يستحق القراءة أيضًا

Seeking Alpha

Solid but narrow footing: UBS sees 3.5% global growth driven by AI capex

CNBC

Prediction markets tied to clinical trials and drug approvals draw lawmakers' ire

Investing.com

Northrop Grumman at Baird conference sees durable demand, growth

MarketWatch

Need money for a down payment? More employers are offering to help.

Yahoo Finance

Crypto-Style Perpetual Futures Will Soon Be Available For Individual Stocks. Here's What Investors Need to Know.

TheStreet